Skip to content

QuantX Breast MRI SE

by Qlarity Imaging

QuantX Breast MRI SE (3) is a Class II device made by Qlarity Imaging, cleared under FDA 510(k) K170195 on 17 May 2017 and listed in FDA GUDID since 19 Feb 2020 (UDI-DI B80731), active (FDA 510(k)), not in commercial distribution (GUDID) as of 23 Oct 2026.

Active United States. Also listed in GUDID (US), not in commercial distribution.

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K170195

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB80731 UDI-DI Date19 Feb 2020ListedStatusListed GUDID: not in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK170195 Date17 May 2017DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K170195 decided 17 May 2017 Active
  • FDA GUDID UDI-DI B80731 listed 19 Feb 2020 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K170195
  2. Listed FDA GUDID B80731

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
QuantX
Generic name
Radiological PACS-dedicated management software
Model / Ref / Catalog
Breast MRI SE, 3
Primary DI / UDI-DI
B80731
510(k) Number
FDA product code
LLZ
GMDN term
Radiological PACS-dedicated management software
Device class
Class II
Regulation number
892.2050
GUDID distribution status
Not in Commercial Distribution

Similar devices

Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).

Other devices from Qlarity Imaging

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)